Trial intelligence / Profile preview

Diltiazem for overactive bladder syndrome

IRCT201105096424N1Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of diltiazem in overactive bladder (OAB), sponsored by Kermanshah University of Medical Sciences. Started May 2011; status: completed.

02

Drugs

diltiazem
03

Conditions

overactive bladder (OAB)

Beyond the preview

Go deeper on IRCT201105096424N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201105096424N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call